CASI Pharmaceuticals Statistics

Total Valuation

CASI has a market cap or net worth of $40.59 million. The enterprise value is $38.90 million.

Market Cap	40.59M
Enterprise Value	38.90M

Important Dates

The last earnings date was Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

CASI has 15.49 million shares outstanding. The number of shares has increased by 3.62% in one year.

Current Share Class	15.49M
Shares Outstanding	15.49M
Shares Change (YoY)	+3.62%
Shares Change (QoQ)	+13.13%
Owned by Insiders (%)	5.00%
Owned by Institutions (%)	2.50%
Float	6.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.65
Forward PS	5.38
PB Ratio	2.89
P/TBV Ratio	3.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 1.38.

Current Ratio	3.20
Quick Ratio	2.17
Debt / Equity	1.38
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-178.66

Financial Efficiency

Return on equity (ROE) is -95.77% and return on invested capital (ROIC) is -47.39%.

Return on Equity (ROE)	-95.77%
Return on Assets (ROA)	-28.68%
Return on Capital (ROIC)	-47.39%
Revenue Per Employee	$125,313
Profits Per Employee	-$175,938
Employee Count	176
Asset Turnover	0.32
Inventory Turnover	0.93

Taxes

Income Tax	-1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.39% in the last 52 weeks. The beta is 0.60, so CASI's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-51.39%
50-Day Moving Average	3.79
200-Day Moving Average	4.68
Relative Strength Index (RSI)	38.56
Average Volume (20 Days)	42,195

Short Selling Information

The latest short interest is 60,964, so 0.39% of the outstanding shares have been sold short.

Short Interest	60,964
Short Previous Month	42,486
Short % of Shares Out	0.39%
Short % of Float	0.88%
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, CASI had revenue of $22.06 million and -$30.97 million in losses. Loss per share was -$2.23.

Revenue	22.06M
Gross Profit	11.98M
Operating Income	-31.62M
Pretax Income	-27.02M
Net Income	-30.97M
EBITDA	-26.89M
EBIT	-31.62M
Loss Per Share	-$2.23

Full Income Statement

Balance Sheet

The company has $20.81 million in cash and $19.12 million in debt, giving a net cash position of $1.69 million or $0.11 per share.

Cash & Cash Equivalents	20.81M
Total Debt	19.12M
Net Cash	1.69M
Net Cash Per Share	$0.11
Equity (Book Value)	13.85M
Book Value Per Share	0.91
Working Capital	32.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 54.31%, with operating and profit margins of -143.38% and -140.30%.

Gross Margin	54.31%
Operating Margin	-143.38%
Pretax Margin	-139.56%
Profit Margin	-140.30%
EBITDA Margin	-121.93%
EBIT Margin	-143.38%
FCF Margin	n/a

Dividends & Yields

CASI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.62%
Shareholder Yield	-3.62%
Earnings Yield	-76.29%
FCF Yield	n/a

Analyst Forecast

The average price target for CASI is $6.00, which is 129.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	129.01%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	21.20%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 2, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 2, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

CASI has an Altman Z-Score of -14.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.97
Piotroski F-Score	n/a